Logo image of ACX.DE

BET-AT-HOME.COM AG (ACX.DE) Stock Fundamental Analysis

FRA:ACX - DE000A0DNAY5 - Common Stock

2.71 EUR
-0.03 (-1.09%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

3

Overall ACX gets a fundamental rating of 3 out of 10. We evaluated ACX against 58 industry peers in the Hotels, Restaurants & Leisure industry. No worries on liquidiy or solvency for ACX as it has an excellent financial health rating, but there are worries on the profitability. ACX is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ACX has reported negative net income.
In the past year ACX had a positive cash flow from operations.
In multiple years ACX reported negative net income over the last 5 years.
ACX had a positive operating cash flow in 4 of the past 5 years.
ACX.DE Yearly Net Income VS EBIT VS OCF VS FCFACX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

1.2 Ratios

The Return On Assets of ACX (-15.13%) is worse than 81.03% of its industry peers.
The Return On Equity of ACX (-34.67%) is worse than 65.52% of its industry peers.
Industry RankSector Rank
ROA -15.13%
ROE -34.67%
ROIC N/A
ROA(3y)2.63%
ROA(5y)2.17%
ROE(3y)5.43%
ROE(5y)-6.73%
ROIC(3y)N/A
ROIC(5y)N/A
ACX.DE Yearly ROA, ROE, ROICACX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

In the last couple of years the Operating Margin of ACX has declined.
The Gross Margin of ACX (78.97%) is better than 82.76% of its industry peers.
In the last couple of years the Gross Margin of ACX has remained more or less at the same level.
ACX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.97%
OM growth 3Y-58.22%
OM growth 5Y-42.67%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.6%
ACX.DE Yearly Profit, Operating, Gross MarginsACX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

7

2. Health

2.1 Basic Checks

ACX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ACX remains at a similar level compared to 1 year ago.
The number of shares outstanding for ACX remains at a similar level compared to 5 years ago.
ACX has a better debt/assets ratio than last year.
ACX.DE Yearly Shares OutstandingACX.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
ACX.DE Yearly Total Debt VS Total AssetsACX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

An Altman-Z score of 2.18 indicates that ACX is not a great score, but indicates only limited risk for bankruptcy at the moment.
ACX has a Altman-Z score of 2.18. This is in the better half of the industry: ACX outperforms 63.79% of its industry peers.
The Debt to FCF ratio of ACX is 1.85, which is an excellent value as it means it would take ACX, only 1.85 years of fcf income to pay off all of its debts.
ACX's Debt to FCF ratio of 1.85 is amongst the best of the industry. ACX outperforms 86.21% of its industry peers.
ACX has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
ACX's Debt to Equity ratio of 0.05 is amongst the best of the industry. ACX outperforms 89.66% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 1.85
Altman-Z 2.18
ROIC/WACCN/A
WACC6.98%
ACX.DE Yearly LT Debt VS Equity VS FCFACX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

ACX has a Current Ratio of 1.51. This is a normal value and indicates that ACX is financially healthy and should not expect problems in meeting its short term obligations.
ACX has a better Current ratio (1.51) than 89.66% of its industry peers.
ACX has a Quick Ratio of 1.51. This is a normal value and indicates that ACX is financially healthy and should not expect problems in meeting its short term obligations.
ACX's Quick ratio of 1.51 is amongst the best of the industry. ACX outperforms 93.10% of its industry peers.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.51
ACX.DE Yearly Current Assets VS Current LiabilitesACX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

1

3. Growth

3.1 Past

The earnings per share for ACX have decreased strongly by -167.31% in the last year.
ACX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.37%.
The Revenue for ACX have been decreasing by -18.26% on average. This is quite bad
EPS 1Y (TTM)-167.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%132.78%
Revenue 1Y (TTM)14.37%
Revenue growth 3Y-4.13%
Revenue growth 5Y-18.26%
Sales Q2Q%15.21%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.64%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACX.DE Yearly Revenue VS EstimatesACX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
ACX.DE Yearly EPS VS EstimatesACX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 4

4

4. Valuation

4.1 Price/Earnings Ratio

ACX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 4.33, which indicates a rather cheap valuation of ACX.
Based on the Price/Forward Earnings ratio, ACX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of ACX to the average of the S&P500 Index (22.69), we can say ACX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 4.33
ACX.DE Price Earnings VS Forward Price EarningsACX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 24.97
EV/EBITDA N/A
ACX.DE Per share dataACX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

ACX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ACX!.
Industry RankSector Rank
Dividend Yield N/A

BET-AT-HOME.COM AG

FRA:ACX (9/5/2025, 7:00:00 PM)

2.71

-0.03 (-1.09%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-14 2025-05-14
Earnings (Next)09-23 2025-09-23
Inst Owners0.3%
Inst Owner ChangeN/A
Ins Owners58.83%
Ins Owner ChangeN/A
Market Cap19.02M
Analysts45.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.33
P/S 0.25
P/FCF 24.97
P/OCF 24.02
P/B 0.83
P/tB 0.89
EV/EBITDA N/A
EPS(TTM)-1.06
EYN/A
EPS(NY)0.63
Fwd EY23.11%
FCF(TTM)0.11
FCFY4.01%
OCF(TTM)0.11
OCFY4.16%
SpS10.86
BVpS3.28
TBVpS3.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.13%
ROE -34.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.97%
FCFM 1%
ROA(3y)2.63%
ROA(5y)2.17%
ROE(3y)5.43%
ROE(5y)-6.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-58.22%
OM growth 5Y-42.67%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.6%
F-Score5
Asset Turnover1.45
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 1.85
Debt/EBITDA N/A
Cap/Depr 2.37%
Cap/Sales 0.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 1.51
Altman-Z 2.18
F-Score5
WACC6.98%
ROIC/WACCN/A
Cap/Depr(3y)22.88%
Cap/Depr(5y)42.26%
Cap/Sales(3y)0.89%
Cap/Sales(5y)1.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-167.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%132.78%
EPS Next Y24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.37%
Revenue growth 3Y-4.13%
Revenue growth 5Y-18.26%
Sales Q2Q%15.21%
Revenue Next Year7.64%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-55.43%
EBIT growth 3Y-59.94%
EBIT growth 5Y-53.14%
EBIT Next Year80%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y371.17%
FCF growth 3Y-55.42%
FCF growth 5Y-51.16%
OCF growth 1Y661.54%
OCF growth 3Y-57.74%
OCF growth 5Y-51.62%